Literature DB >> 7951317

Cooperative tumorigenic effects of germline mutations in Rb and p53.

B O Williams1, L Remington, D M Albert, S Mukai, R T Bronson, T Jacks.   

Abstract

The tumour suppressor genes Rb and p53 are mutated in several types of human cancer, and many tumour types carry mutations in both genes. To study how these genes normally function, we and others have created mouse strains with Rb and p53 mutations. Here we describe the phenotypic effects of combined germline mutations in these two tumour suppressor genes. Mice mutant for both genes have reduced viability and exhibit novel pathology including pinealoblastomas, islet cell tumours, bronchial epithelial hyperplasia and retinal dysplasia. These data indicate that mutations in Rb and p53 can cooperate in the transformation of certain cell types in the mouse.

Entities:  

Mesh:

Year:  1994        PMID: 7951317     DOI: 10.1038/ng0894-480

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  118 in total

1.  Conditional mutation of Rb causes cell cycle defects without apoptosis in the central nervous system.

Authors:  D MacPherson; J Sage; D Crowley; A Trumpp; R T Bronson; T Jacks
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

2.  Genetic interaction between Rb and K-ras in the control of differentiation and tumor suppression.

Authors:  Chiaki Takahashi; Bernardo Contreras; Roderick T Bronson; Massimo Loda; Mark E Ewen
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

3.  Estradiol-dependent uterine leiomyomas in transgenic mice.

Authors:  B Romagnolo; T Molina; G Leroy; C Blin; A Porteux; M Thomasset; A Vandewalle; A Kahn; C Perret
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

4.  Deletion of RB exons 24 and 25 causes low-penetrance retinoblastoma.

Authors:  R Bremner; D C Du; M J Connolly-Wilson; P Bridge; K F Ahmad; H Mostachfi; D Rushlow; J M Dunn; B L Gallie
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

5.  Deletions of the INK4A gene occur in malignant peripheral nerve sheath tumors but not in neurofibromas.

Authors:  H P Kourea; I Orlow; B W Scheithauer; C Cordon-Cardo; J M Woodruff
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

Review 6.  Retinoblastoma, the visible CNS tumor: A review.

Authors:  Helen Dimaras; Timothy W Corson
Journal:  J Neurosci Res       Date:  2018-01-03       Impact factor: 4.164

7.  Tissue-specific tumor suppressor activity of retinoblastoma gene homologs p107 and p130.

Authors:  Jan-Hermen Dannenberg; Leontine Schuijff; Marleen Dekker; Martin van der Valk; Hein te Riele
Journal:  Genes Dev       Date:  2004-12-01       Impact factor: 11.361

8.  RB1 deficiency in triple-negative breast cancer induces mitochondrial protein translation.

Authors:  Robert A Jones; Tyler J Robinson; Jeff C Liu; Mariusz Shrestha; Veronique Voisin; YoungJun Ju; Philip E D Chung; Giovanna Pellecchia; Victoria L Fell; SooIn Bae; Lakshmi Muthuswamy; Alessandro Datti; Sean E Egan; Zhe Jiang; Gustavo Leone; Gary D Bader; Aaron Schimmer; Eldad Zacksenhaus
Journal:  J Clin Invest       Date:  2016-08-29       Impact factor: 14.808

9.  Components of the Rb pathway are critical targets of UV mutagenesis in a murine melanoma model.

Authors:  Karuppiah Kannan; Norman E Sharpless; Jin Xu; Ronan C O'Hagan; Marcus Bosenberg; Lynda Chin
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-21       Impact factor: 11.205

10.  p18Ink4c and p53 Act as tumor suppressors in cyclin D1-driven primitive neuroectodermal tumor.

Authors:  Raya Saab; Carlos Rodriguez-Galindo; Kelly Matmati; Jerold E Rehg; Shannon H Baumer; Joseph D Khoury; Catherine Billups; Geoffrey Neale; Kathleen J Helton; Stephen X Skapek
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.